Skip to search formSkip to main contentSkip to account menu

SNC 80

Known as: SNC-80, SNC80 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Oxytocin as a Potential Therapeutic Target for Schizophrenia and Other Neuropsychiatric Conditions
Oxytocin as a Potential Therapeutic Target for Schizophrenia and Other Neuropsychiatric Conditions 
Highly Cited
2009
Highly Cited
2009
The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats.
2008
2008
The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum
2006
2006
Delta opioid agonists attenuate TAT(1-72)-induced oxidative stress in SK-N-SH cells.
2005
2005
The delta opioid receptor agonist, SNC80, has complex, dose-dependent effects on pilocarpine-induced seizures in Sprague–Dawley rats
Highly Cited
2002
Highly Cited
2002
Kappa opioid antagonist effects of the novel kappa antagonist 5′-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys
Abstract.Rationale: Opioid receptors are divided into three types: kappa, mu, and delta receptors. Receptor-selective antagonists… 
2002
2002
Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys.
Dextromethorphan (DXM) is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist shown to prevent the development of… 
2001
2001
Parallel synthesis and biological activity of a new class of high affinity and selective delta-opioid ligand.
2000
2000
Modulation of adenosine concentration by opioid receptor agonists in rat striatum.
1998
1998
Delta-opioid suppression of human immunodeficiency virus-1 expression in T cells (Jurkat).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)